At Techsol, we are closely monitoring the impact of coronavirus (COVID-19) as it continues to affect across the world. As always we are committed to supporting your business and provide continuity of service as the information around the virus continues to unfold.
We realize that in this time of crisis, it is critical that we make it possible for you to continue your operations and help you respond to the unique demands that you may be facing. We have been in business for close to a decade supporting critical operations performed by biopharmaceutical companies, service providers, and research organizations. We want you to know that at this important time, you can count on us to be there to continue to support your business operations.
Techsol remains committed to meeting its SLAs (service level agreements) for our cloud and project delivery services. Our leadership team is meeting continuously to assess the situation and appropriately respond to the crisis as it evolves. We maintain a Business Continuity program reviewed on an annual basis. We take an impact-based approach to business continuity management by designing preparedness and response plans that address the availability of our team members, development/ delivery offices, cloud infrastructure and their critical interdependencies. Techsol’s geographic diversification provide an inherent resiliency advantage. We have online collaboration capabilities for our global and local employees to communicate with each other, with you and vendors.
Our global support teams working tirelessly to continue to serve you. Techsol will advise you of any important service notifications or questions and concerns regarding our business continuity via Service Desk. Please reach out to our Service Desk via email email@example.com or via Service Desk Portal with any additional questions and concerns.
Satya S. S. Sagi
Chief Executive Officer
Techsol Life Sciences